Instalab

Omega-3 Index Test Blood

A risk factor for heart disease and early death that your standard cholesterol panel completely misses.

Should you take a Omega-3 Index test?

This test is most useful if any of these apply to you.

Worried About Heart Disease
See a cardiovascular risk factor that your cholesterol panel never checks, even if your LDL looks fine.
Taking Fish Oil Supplements
Find out whether your supplement is actually raising your levels to the protective range, or falling short.
Eating Plant-Based or Low-Fish
Check whether your diet is leaving a gap in the two omega-3 fats most linked to longevity and heart health.
Staying Sharp as You Age
Track the omega-3 status tied to brain volume, memory, and lower risk of frailty in large aging studies.

About Omega-3 Index

If you could check one number to gauge how well your body is stocked with the fats most consistently linked to a longer life, this would be it. The Omega-3 Index measures how much EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), the two long-chain omega-3 fats found in fish and marine oils, have actually been incorporated into your red blood cell membranes. It is expressed as a simple percentage.

What makes this number so useful is that it does not bounce around with your last meal or even your last week of eating. Because red blood cells live for about 120 days, the Omega-3 Index reflects roughly three to four months of your true omega-3 status. Think of it the way HbA1c (a three-month average of blood sugar) relates to a single fasting glucose reading: one gives you a snapshot, the other gives you the full picture.

Why This Number Matters for Your Heart

The connection between the Omega-3 Index and cardiovascular outcomes has been tested in some of the largest and longest-running cohort studies in nutrition science. In the Framingham Heart Study, about 2,500 adults were followed for a median of 7.3 years. Those in the top fifth of the index (above roughly 6.8%) had about 34% lower risk of dying from any cause and 39% lower risk of developing cardiovascular disease compared with those in the bottom fifth (below about 4.2%), after adjusting for 18 different risk factors. The Omega-3 Index actually outperformed total cholesterol as a mortality predictor in those models.

A pooled analysis of 10 cohort studies estimated that moving your Omega-3 Index from about 4% up to about 8% is associated with roughly 30% lower risk of fatal coronary heart disease. And in a massive 17-cohort analysis of over 42,000 people followed for a median of 16 years, those in the highest fifth of circulating EPA and DHA had about 15 to 18% lower risk of death from all causes, cardiovascular disease, and cancer, after accounting for standard risk factors.

If you already have coronary artery disease and take a statin, omega-3 status still adds information your lipid panel cannot. In a study of 218 statin-treated patients with coronary disease, those who achieved a plasma omega-3 index (a related measurement based on blood plasma rather than red blood cells) of 4% or higher showed no progression of coronary plaque, while those below 3.43% continued to accumulate plaque despite statin therapy.

All-Cause Mortality and Longevity

The mortality data extend well beyond heart disease. In the UK Biobank, a study of over 85,000 adults, those in the highest fifth of plasma omega-3 levels (a related measurement that reflects shorter-term intake than the red blood cell-based Omega-3 Index) had roughly 30% lower risk of dying from any cause and from cardiovascular disease, and about 25% lower risk of dying from cancer. A separate meta-analysis of 67 prospective studies covering over 310,000 participants found that higher marine omega-3 biomarker levels were associated with lower risk of total cardiovascular disease, coronary heart disease, all-cause mortality, and colorectal cancer.

In older adults, the benefits go beyond just survival. The Cardiovascular Health Study followed over 2,600 adults aged 65 and older for roughly 13 years with serial measurements. For each increase from the lowest to the highest fifth of long-chain omega-3 levels, there was an 18% lower risk of what the researchers called "unhealthy aging," a composite of chronic disease, cognitive decline, physical decline, or death.

Brain Health and Cognitive Function

Your brain is one of the most omega-3-rich organs in your body, and the Omega-3 Index appears to reflect that relationship. In about 2,183 middle-aged adults from the Framingham Study, higher red blood cell omega-3 levels were associated with larger hippocampal volume (the brain region central to memory) and better performance on abstract reasoning tests.

In the Alzheimer's Disease Neuroimaging Initiative, a study of 832 older adults, very low red blood cell omega-3 levels (around 3.6 to 3.7%) were associated with greater accumulation of amyloid-beta, the protein that builds up in Alzheimer's disease, and with specific memory decline. The association was stronger in carriers of the APOE4 gene variant (apolipoprotein E4, a genetic risk factor for Alzheimer's).

Kidney Health

A pooled analysis of 19 cohorts including over 25,500 participants followed for a median of 11.3 years found that people in the highest fifth of seafood-derived omega-3 levels had 13% lower risk of developing chronic kidney disease after adjusting for multiple risk factors. Plant-derived omega-3 (ALA, or alpha-linolenic acid) showed no such association, reinforcing that this test specifically tracks the marine omega-3s that matter for this outcome.

Frailty and Physical Aging

The Korean Frailty and Aging Cohort Study followed 1,119 community-dwelling older adults for six years. Higher red blood cell levels of EPA and DHA were associated with lower rates of new frailty and lower mortality. In heart failure patients with preserved pumping function (a condition called HFpEF), higher omega-3 blood levels were tied to lower body mass, smaller waists, better blood sugar control, lower triglycerides, and better aerobic exercise capacity.

Inflammation

The Omega-3 Index is inversely tied to multiple markers of body-wide inflammation. In about 2,724 adults from the Framingham cohort, higher red blood cell omega-3 levels were modestly but consistently associated with lower levels of several inflammatory proteins. In 64 patients with peripheral artery disease (narrowed blood vessels in the legs), the Omega-3 Index was inversely linked to CRP (C-reactive protein, a common inflammation marker) and IL-6 (interleukin-6, another inflammatory signal), suggesting that higher omega-3 incorporation into cell membranes tracks with a less inflamed body.

Atrial Fibrillation and Omega-3 Levels

Some people worry that omega-3 supplementation might trigger atrial fibrillation (an irregular heart rhythm). A large pooled analysis of 17 cohorts, including nearly 55,000 participants followed for a median of 13.3 years with over 7,700 new cases of atrial fibrillation, found no increased risk associated with higher omega-3 levels in the blood. Higher DHA and DPA (docosapentaenoic acid, a related omega-3) were actually associated with modestly lower risk. Some randomized trials of very high-dose prescription omega-3 formulations (around 4 grams per day) have reported modestly higher atrial fibrillation rates, but the biomarker data on habitual omega-3 levels does not show this pattern.

Reference Ranges

The Omega-3 Index is reported as EPA plus DHA as a weight percentage of total red blood cell fatty acids. The risk categories below come from multiple large cohort studies and meta-analyses, primarily in North American and European populations. They are research-derived thresholds, not yet standardized across all clinical labs. Your own lab may use slightly different reporting formats, so compare your results within the same lab over time.

Risk TierOmega-3 Index (%)What It Suggests
High riskBelow 4%Associated with the highest rates of fatal heart disease, higher inflammation, and faster cardiovascular decline.
Intermediate4% to 8%Lower risk than the high-risk zone, but still below the level linked to the strongest protection. Most Americans fall here or below.
Optimal / Low risk8% or aboveAssociated with roughly 30% lower fatal heart disease risk compared with below 4%, lower all-cause mortality, and the best cardiometabolic profiles in published studies.

Globally, average levels vary enormously. Japan and Scandinavia tend to have population averages above 8%, while most of North America, Europe, the Middle East, and large parts of Asia and Africa cluster at 4 to 6%. The average American sits around 4 to 5%, squarely in the intermediate-to-high-risk zone. The cutpoints of 4% and 8% are applied uniformly in the research and are not currently adjusted for age, sex, or ethnicity.

When Results Can Be Misleading

Because the Omega-3 Index is measured in red blood cells that turn over every three to four months, it is one of the more stable biomarkers you can order. A single fish dinner the night before your blood draw will not meaningfully change your result. Fasting is generally not required.

That said, a few factors can complicate interpretation. Statin therapy has been shown to alter the usual correlations between omega-3 levels and standard lipid markers like LDL and triglycerides. Your Omega-3 Index itself may still be accurate, but the way it relates to the rest of your lipid panel may look different on statins. Also, in acutely critically ill patients (for example, in an ICU setting), the index has shown weak or no ability to predict outcomes, likely because the extreme metabolic stress of acute illness disrupts normal fatty acid metabolism.

Body weight also matters for interpretation. At the same dose of EPA and DHA, a person with a higher body mass will typically see a smaller increase in their Omega-3 Index. This does not mean the test is wrong; it means larger individuals may need higher doses to reach the same target.

Any condition that shortens red blood cell lifespan, such as certain anemias that cause red blood cells to break down prematurely or a recent blood transfusion, can make your Omega-3 Index reflect a shorter time window than the usual three to four months. If you have a known blood disorder or have recently received a transfusion, mention this when discussing your results.

What Moves This Biomarker

Evidence-backed interventions that affect your Omega-3 Index level

↑ Increase
Take EPA and DHA supplements in triglyceride form (the natural fat form found in fish oil)
Triglyceride-form fish oil raises your Omega-3 Index faster and higher than the ethyl ester form (a chemically modified version of fish oil) commonly sold in drugstores. In a randomized trial of 150 adults, triglyceride-form supplements produced a significantly greater increase in the Omega-3 Index over six months compared with ethyl esters at the same dose. Across 58 studies reviewed, 1,000 to 1,500 mg per day of combined EPA and DHA in triglyceride form for at least 12 weeks was typically sufficient to push most people toward or above the 8% target. In a dose-response trial of 115 healthy adults, 1,800 mg per day for about five months raised the median Omega-3 Index from 4.3% to 9.9%, while 900 mg per day reached 7.6%.
SupplementStrong Evidence
↑ Increase
Take EPA and DHA from krill oil
Krill oil raises the Omega-3 Index more effectively than fish oil at equivalent EPA and DHA doses. In a 4-week randomized trial of 24 healthy adults, krill oil produced a greater increase in the Omega-3 Index than standard fish oil. In a separate trial of 78 patients with lupus (SLE, systemic lupus erythematosus), 4 grams per day of krill oil concentrate raised the mean Omega-3 Index from about 4.4% to above 8% within 24 weeks and also improved disease activity in those with more active disease.
SupplementStrong Evidence
↑ Increase
Take EPA and DHA supplements in ethyl ester form
Ethyl ester fish oil (the most common over-the-counter form, a chemically modified version) does raise your Omega-3 Index, but less efficiently than triglyceride or krill oil forms. In heart failure patients taking 1 gram per day of ethyl esters, the Omega-3 Index rose from 4.8% to 6.7% over three months, but only 22.6% of participants reached the 8% target. You may need higher doses or longer treatment to hit your goal with this formulation.
SupplementModerate Evidence
↑ Increase
Eat fatty fish three times per week
A diet including three servings of fatty fish per week raises the Omega-3 Index, but the response depends heavily on your body composition and starting level. In a randomized trial of 42 overweight to obese women, 8 weeks of three fatty fish meals per week increased the index, but women with more body fat saw smaller gains. In a large review of 58 studies, 83% of people eating two or more fatty fish servings per week still had an Omega-3 Index below 8%. To reliably reach 8%, most people needed to supplement with at least 1,000 mg per day of combined EPA and DHA.
DietModerate Evidence
↑ Increase
Eat omega-3 enriched foods (such as omega-3 enriched chicken and eggs)
Regularly eating foods that have been fortified with omega-3 fats can raise your Omega-3 Index modestly. In a 6-month randomized trial of 161 adults, consuming omega-3 enriched chicken and eggs increased the Omega-3 Index by about 1.7 percentage points and cut the proportion of participants with a very low index (below 4%) roughly in half. This approach also lowered diastolic blood pressure. However, enriched foods alone are unlikely to push most people above 8%.
DietModest Evidence
↑ Increase
Take plant-based omega-3 (ALA from flaxseed or similar sources)
Plant-based omega-3s contain ALA (alpha-linolenic acid), which your body converts very inefficiently into EPA and barely at all into DHA. In supplementation studies, flaxseed oil raised EPA in red blood cells but did not significantly increase DHA. Current ALA and fish intake recommendations are generally inadequate for most people to reach an Omega-3 Index of 8%. If you follow a vegan or vegetarian diet and want to raise your Omega-3 Index, algae-based EPA and DHA supplements are a more direct option.
SupplementModest Evidence

Frequently Asked Questions

References

45 studies
  1. Clinical Correlates and Heritability of Erythrocyte Eicosapentaenoic and Docosahexaenoic Acid Content in the Framingham Heart Study.
    Harris WS, Pottala JV, Lacey SM, Vasan RS, Larson MG, Robins SJAtherosclerosis2012
  2. Optimization of Omega-3 Index Levels in Athletes at the US Naval Academy: Personalized Omega-3 Fatty Acid Dosage and Molecular Genetic Approaches
    Rittenhouse M, Sambuughin N, Deuster PNutrients2022
  3. The Omega-3 Index in National Collegiate Athletic Association Division I Collegiate Football Athletes.
    Anzalone a, Carbuhn AF, Jones L, Gallop a, Smith a, Johnson P, Swearingen L, Moore C, Rimer E, Mcbeth J, Harris WS, Kirk KM, Gable DA, Askow AT, Jennings W, Oliver JMJournal of Athletic Training2019
  4. The Influence of Dietary and Supplemental Omega-3 Fatty Acids on the Omega-3 Index: A Scoping Review
    Dempsey M, Rockwell M, Wentz LMFrontiers in Nutrition2023
  5. The Omega-3 Index: A New Risk Factor for Death From Coronary Heart Disease?
    Harris WS, Von Schacky CPreventive Medicine2004